FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Stent, Superficial Femoral Artery, Drug-Eluting
PMA: P100022
·
Supplement: S039
·
Decision May 13, 2022
Classifications
1
FEI Numbers
9
Registration Numbers
9
Basic Information
- Device Name
- Stent, Superficial Femoral Artery, Drug-Eluting
- Trade Name
- Zilver® PTX® Drug-Eluting Peripheral Stent
- PMA Number
- P100022
- Supplement Number
- S039
- Device Class
- FDA Class 3
- Product Code
- NIU
- Generic Name
- Stent, superficial femoral artery, drug-eluting
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- May 13, 2022
- Date Received
- September 30, 2021
- Supplement Type
- 135 Review Track For 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Approval for a site change of an Active Pharmaceutical Ingredient (API) supplier.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NIU | Stent, Superficial Femoral Artery, Drug-Eluting | FDA class 3 | Unknown |